APUS
AMEX
$0.64
Apimeds Pharmaceuticals US Inc (APUS)
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company in the United States. The company is headquartered in Hopewell, New Jersey.
Sector:
Healthcare
Market Cap
$8.51M
P/B Ratio
0.09
Beta (5Y)
0.79
Price Chart
Valuation
Market Cap$8.51M
P/B0.09
Profitability
EBITDA-$25M
EPS-$3.23
Growth & Risk
Beta (5Y)0.79
Sharpe Ratio-0.05